Mitochondrial translocator protein (TSPO) ligands prevent doxorubicin-induced mechanical dysfunction and cell death in isolated cardiomyocytes.

Abstract : Contractile dysfunction and subsequent development of cardiomyopathies are well known limiting factors in the treatment of cancer with doxorubicin and have been linked to mitochondrial dysfunction. Here, using adult isolated paced cardiomyocytes, we have demonstrated that ligands of translocator protein (TSPO) 4'-chlorodiazepam and TRO40303 prevented the doxorubicin-induced alterations in contractility and improved cardiomyocyte viability. This cardioprotective effect was closely associated with both a potent reduction in reactive oxygen species production and inhibition of mitochondrial permeability transition pore opening. Thus, preventive administration of TSPO ligands may represent a novel pharmacological strategy to protect the heart during doxorubicin treatment.
Type de document :
Article dans une revue
Mitochondrion, Elsevier, 2013, 13 (6), pp.688-97. 〈10.1016/j.mito.2013.10.001〉
Liste complète des métadonnées

Littérature citée [5 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00920557
Contributeur : Georges Guellaen <>
Soumis le : mercredi 18 décembre 2013 - 16:59:27
Dernière modification le : mercredi 27 janvier 2016 - 17:38:07
Document(s) archivé(s) le : mercredi 19 mars 2014 - 05:52:38

Fichiers

article_mitochondrion_pour_dA_...
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Alexandra d'Anglemont De Tassigny, Rana Assaly, Sophie Schaller, Rebecca Pruss, Alain Berdeaux, et al.. Mitochondrial translocator protein (TSPO) ligands prevent doxorubicin-induced mechanical dysfunction and cell death in isolated cardiomyocytes.. Mitochondrion, Elsevier, 2013, 13 (6), pp.688-97. 〈10.1016/j.mito.2013.10.001〉. 〈inserm-00920557〉

Partager

Métriques

Consultations de la notice

354

Téléchargements de fichiers

649